Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harvard Bioscience (HBIO) Cash from Operations (2016 - 2025)

Harvard Bioscience (HBIO) has disclosed Cash from Operations for 16 consecutive years, with 1084000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Cash from Operations rose 228.74% to 1084000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was 8550000.0, a 112.79% increase, with the full-year FY2024 number at 1440000.0, down 89.73% from a year prior.
  • Cash from Operations was 1084000.0 for Q3 2025 at Harvard Bioscience, down from 2755000.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 4361000.0 in Q3 2023 to a low of 1986000.0 in Q1 2022.
  • A 5-year average of 1300368.42 and a median of 1084000.0 in 2025 define the central range for Cash from Operations.
  • Biggest YoY gain for Cash from Operations was 2189.74% in 2022; the steepest drop was 291.51% in 2022.
  • Harvard Bioscience's Cash from Operations stood at 117000.0 in 2021, then surged by 2189.74% to 2679000.0 in 2022, then surged by 60.62% to 4303000.0 in 2023, then tumbled by 59.91% to 1725000.0 in 2024, then crashed by 37.16% to 1084000.0 in 2025.
  • Per Business Quant, the three most recent readings for HBIO's Cash from Operations are 1084000.0 (Q3 2025), 2755000.0 (Q2 2025), and 2986000.0 (Q1 2025).